haemate p 500 iu fviii 1200 iu vwf
csl behring ltd., israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection/infusion - factor viii (human) 500 iu / 10 ml; von willebrand factor 1200 iu / 10 ml - coagulation factor xiii - coagulation factor xiii - congenital and acquired deficiency of blood clotting factor viii: severe or moderate haemophilia, prophylaxis during operation, von willebrands disease.
feiba 25units/ml (500unit) powder and 20ml solvent for solution for infusion vials
500unit) powder and 20ml solvent for solution for infusion vials (takeda uk ltd - factor viii inhibitor bypassing fraction - powder and solvent for solution for infusion - 500unit
biostate human coagulation factor viii 500iu / von willebrand factor 1200iu powder for injection vial with diluent vial
csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1200 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.
biostate human coagulation factor viii 250iu / von willebrand factor 600iu powder for injection vial with diluent vial
csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 600 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.
kovaltry 1000 iu
bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 1000 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.
feiba 50 u/ml powder and solvent for solution for infusion
baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - powder and solvent for solution for infusion - factor viii inhibitor bypassing fraction 50 u/ml - antihemorrhagics
feiba 100 u/ml powder and solvent for solution for infusion (500 u/5 ml)
baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - powder and solvent for solution for infusion - factor viii inhibitor bypassing fraction 100 u/ml - antihemorrhagics
medicinal product name : feiba 100 u/ml powder and solvent for solution for infusion (2500 u/25 ml)
baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - powder and solvent for solution for infusion - factor viii inhibitor bypassing fraction 100 u/ml - antihemorrhagics
octanate 1000
dover medical & scientific equipment ltd, israel - factor viii - powder and solvent for solution for injection - factor viii 1000 iu/vial - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).this preparation does not contain von willebrand factor in pharmacologically effective quantities and is therefore not indicated in von willebrand’s disease.
feiba 1000 u/20 ml (50 u/ml) powder for solution for infusion (iv)
n/a; importer: takeda healthcare philippines inc.; distributor: takeda healthcare philippines inc. - factor viii inhibitor bypassing activity - powder for solution for infusion (iv) - 1000 u/20 ml (50 u/ml)